Literature DB >> 31672426

Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak.

Gökhan Metan1, Pınar Zarakolu2, Barış Otlu3, İlknur Tekin4, Hanife Aytaç4, Ertuğrul Ç Bölek5, Baki C Metin6, Ethem M Arsava7, Serhat Ünal8.   

Abstract

BACKGROUND: Colistin and carbapenem-resistant Acinetobacter calcoaceticus- Acinetobacter baumannii complex (CCR-Acb complex) was isolated from two consecutive patients in the neurological intensive care unit (NICU). An urgent reaction to this desperate situation was required. PATIENTS AND METHODS: Screening cultures were taken from the other patients sharing the NICU with index patients and repeated periodically. NICU was closed for new admissions. Infection control precautions (ICP) such as hand hygiene, cohorting patients colonized with CCR-Acb complex, cohorting the staff caring for these patients, daily bathing with chlorhexidine gluconate impregnated clothes, using gowns when contacting with patients and patient care area, and sodium hypochlorite tablets for environmental cleaning were enforced.
RESULTS: Screening cultures revealed carbapenem-resistant Acb complex in 12 out of 32 patients and 8 of them were colonized with CCR-Acb complex. NICU was opened for new admissions one month later. No further new cases with CCR-Acb complex were detected by screening cultures after 6 weeks with enforcement of ICP. Moreover, the rate of nosocomial infections caused by other multi-drug resistant Gram-negative bacilli (MDR-GNB) decreased significantly when rates before and after closing the NICU were compared.
CONCLUSION: ICP were effective not only to limit the spread of CCR-Acb complex but also decreased the incidence of other MDR-GNB infections when applied adequately.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; Carbapenem resistance; Colistin resistance; ICU; Intensive care unit

Mesh:

Substances:

Year:  2019        PMID: 31672426     DOI: 10.1016/j.jiph.2019.09.013

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  5 in total

1.  A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.

Authors:  Marianna Meschiari; José-María Lòpez-Lozano; Vincenzo Di Pilato; Carola Gimenez-Esparza; Elena Vecchi; Erica Bacca; Gabriella Orlando; Erica Franceschini; Mario Sarti; Monica Pecorari; Antonella Grottola; Claudia Venturelli; Stefano Busani; Lucia Serio; Massimo Girardis; Gian Maria Rossolini; Inge C Gyssens; Dominique L Monnet; Cristina Mussini
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-19       Impact factor: 4.887

2.  The impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospital.

Authors:  Gökhan Metan; Mervenur Demir Çuha; Gülsen Hazirolan; Gülçin Telli Dizman; Elif Seren Tanriverdi; Baris Otlu; Zahit Tas; Pinar Zarakolu; Zafer Arik; Arzu Topeli; Seda Banu Akinci; Serhat Ünal; Ömrüm Uzun
Journal:  GMS Hyg Infect Control       Date:  2022-08-29

Review 3.  Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?

Authors:  Filippo Medioli; Erica Bacca; Matteo Faltoni; Giulia Jole Burastero; Sara Volpi; Marianna Menozzi; Gabriella Orlando; Andrea Bedini; Erica Franceschini; Cristina Mussini; Marianna Meschiari
Journal:  Antibiotics (Basel)       Date:  2022-07-28

4.  WGS-Based Analysis of Carbapenem-Resistant Acinetobacter baumannii in Vietnam and Molecular Characterization of Antimicrobial Determinants and MLST in Southeast Asia.

Authors:  Gamal Wareth; Jörg Linde; Ngoc H Nguyen; Tuan N M Nguyen; Lisa D Sprague; Mathias W Pletz; Heinrich Neubauer
Journal:  Antibiotics (Basel)       Date:  2021-05-11

5.  Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019.

Authors:  Felix Lötsch; Barbara Albiger; Dominique L Monnet; Marc J Struelens; Harald Seifert; Anke Kohlenberg
Journal:  Euro Surveill       Date:  2020-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.